Loading...
Preventing thrombosis in a COVID‐19 patient by combined therapy with nafamostat and heparin during extracorporeal membrane oxygenation
BACKGROUND: Preventing thrombosis in extracorporeal membrane oxygenation (ECMO) can be life‐saving in cases of coronavirus disease (COVID‐19); however, circuit thrombosis is a complication. This report describes a COVID‐19 patient treated with nafamostat and heparin to prevent circuit thrombosis dur...
Na minha lista:
| Udgivet i: | Acute Med Surg |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537502/ https://ncbi.nlm.nih.gov/pubmed/33042560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ams2.585 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|